A boy with fatigue and eosinophilia

New England Journal of Medicine

Volumn 350, Issue 25, 2004, Pages 2604-2612

  Huang, Mary S ^a,b   Hasserjian, Robert P ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; CARBAMAZEPINE; GRANULOCYTE COLONY STIMULATING FACTOR; IBUPROFEN; PARACETAMOL; PHENOBARBITAL; PHENYTOIN; RANITIDINE; SULFONAMIDE; ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BODY WEIGHT; CANCER; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; ENDOCRINE DISEASE; EOSINOPHILIA; FAMILIAL DISEASE; FATIGUE; FEVER; HELMINTHIASIS; HUMAN; HUMAN CELL; HYPEREOSINOPHILIC SYNDROME; IMMUNOPATHOLOGY; INFECTION; MALE; MUSCLE CRAMP; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCHOOL CHILD; B CELL LEUKEMIA; BONE MARROW; BONE MARROW EXAMINATION; CHILD; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; FLOW CYTOMETRY; GENE TRANSLOCATION; GENETICS; IN SITU HYBRIDIZATION; NEOPLASM; PATHOLOGY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; BONE MARROW EXAMINATION; CHILD; DIAGNOSIS, DIFFERENTIAL; EOSINOPHILIA; FATIGUE; FLOW CYTOMETRY; HUMANS; IN SITU HYBRIDIZATION; INFECTION; LEUKEMIA, B-CELL, ACUTE; MALE; NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 2942627112     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMcpc049009     Document Type: Article

References (33)

1. Rothenberg ME. Eosinophilia. N Engl J Med 1998;338:1592-600.
2. Kobayashi S, Inokuma S, Setoguchi K, Kono H, Abe K. Incidence of peripheral blood eosinophilia and the threshold eosinophile count for indicating hypereosinophilia-associated diseases. Allergy 2002;57:950-6.
3. Ackerman SJ, Butterfield JH. Eosinophilia, eosinophil-associated diseases, and the hypereosinophilic syndrome. In: Hoffman R, Benz EJ Jr, Shattil SJ, eds. Hematology: basic principles and practice. 3rd ed. New York: Churchill Livingstone, 2000:702-20.
4. Pearson RD, Guerrant RL. Enteric fever and other causes of abdominal symptoms with fever. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 5th ed. Vol. 1. Philadelphia: Churchill Livingstone, 2000:1136-50.
5. Thomeer M, Moerman P, Westhovens R, Van den Eeckhout A, Dequeker J, Demedts M. Systemic lupus erythematosus, eosinophilia and Loffler's endocarditis: an unusual association. Eur Respir J 1999;13:930-3.
6. Panush RS, Franco AE, Schur PH. Rheumatoid arthritis associated with eosinophilia. Ann Intern Med 1971;75:199-205.
7. Clauw DJ, Crofford LJ. Eosinophilic rheumatic disorders. Rheum Dis Clin North Am 1995;21:231-46.
8. Thurlow PJ, Marshall AW. Extreme hypereosinophilia in sclerosing cholangitis. Intern Med J 2003;33:134-6.
9. Drug hypersensitivity syndrome. In: Fitzpatrick TB, Johnson RA, Wolff K. Color atlas and synopsis of clinical dermatology: common and serious diseases. 4th ed. New York: McGraw-Hill, 2001:564-5.
10. Stewart PM. The adrenal cortex. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, ed. Williams textbook of endocrinology. 10th ed. Philadelphia: Saunders, 2003:491-551.
11. Beishuizen A, Vermes I, Hylkema BS, Haanen C. Relative eosinophilia and functional adrenal insufficiency in critically ill patients. Lancet 1999;353:1675-6.
12. Angelis M, Yu M, Takanishi D, Hasaniya NW, Brown MR. Eosinophilia as a marker of adrenal insufficiency in the surgical intensive care unit. J Am Coll Surg 1996;183:589-96.
13. Rioux JD, Stone VA, Daly MJ, et al. Familial eosinophilia maps to the cytokine gene cluster on human chromosomal region 5q31-q33. Am J Hum Genet 1998;63:1086-94.
14. Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood 1994;83:2759-79.
15. Bain BJ. Eosinophilic leukemias and the idiopathic hypereosinophilic syndrome. Br J Haematol 1996;95:2-9.
16. Idem. Hypereosinophilia. Curr Opin Hematol 2000;7:21-5.
17. Schwartz RS. The hypereosinophilic syndrome and the biology of cancer. N Engl J Med 2003;348:1199-200.
18. Simon H-U, Plotz SG, Dummer R, Blaser K. Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med 1999;341:1112-20.
19. Cools J, DeAngelo DJ, Gotlib J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003;348:1201-14.
20. Hogan TF, Koss W, Murgo AJ, Amato RS, Fontana JA, VanScoy FL. Acute lymphoblastic leukemia with chromosomal 5;14 translocation and hypereosinophilia: case report and literature review. J Clin Oncol 1987;5:382-90.
21. Grimaldi JC, Meeker TC. The t(5;14) chromosomal translocation in a case of acute lymphocytic leukemia joins the interleukin-3 gene to the immunoglobulin heavy chain gene. Blood 1989;73:2081-5.
22. Miller KB, Daoust PD. Clinical manifestations of acute myeloid leukemia. In: Hoffman R, Benz EJ Jr, Shattil SJ, eds. Hematology: basic principles and practice. 3rd ed. New York: Churchill Livingstone, 2000:999-1024.
23. Inhorn RC, Aster JC, Roach SA, et al. A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8:13) (p11;q11): description of a distinctive clinicopathologic entity. Blood 1995;85:1881-7.
24. Eapen RS, Lemler MS, Ramaciotti C. Serial echocardiographic changes in a child with hypereosinophilia syndrome. Pediatr Cardiol 2001;22:426.
25. Donahue TP. Loeffler's endocarditis resulting from acute lymphoblastic leukemia. Clin Cardiol 2002;25:345.
26. Horenstein MS, Humes R, Epstein ML, Draper D. Loffler's endocarditis presenting in 2 children as fever with eosinophilia. Pediatrics 2002;110:1014-8.
27. Rimsza LM, Larson RS, Winter SS, et al. Benign hematogone-rich lymphoid proliferations can be distinguished from B-lineage acute lymphoblastic leukemia by integration of morphology, immunophenotype, adhesion molecule expression, and architectural features. Am J Clin Pathol 2000;114:66-75.
28. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Vol. 3 of World Health Organization classification of tumours. Lyon, France: IARC Press, 2001.
29. Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med 2004;350:1535-48.
30. Meeker TC, Hardy D, Willman C, Hogan T, Abrams J. Activation of the interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia. Blood 1990;76:285-9.
31. Friedmann AM, Weinstein HJ. The role of prognostic features in the treatment of childhood acute lymphoblastic leukemia. Oncologist 2000;5:321-8.
32. Shuster JJ, Camitta BM, Pullen J, et al. Identification of newly diagnosed children with acute lymphocytic leukemia at high risk for relapse. Cancer Res Ther Control 1999;9:101-7.
33. Nachman JB, Sather HN, Sensel MG, et al. Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy. N Engl J Med 1998;338:1663-71.